1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Treatment gaps in the care of amyotrophic lateral sclerosis in the Philippines: A scoping review

      review-article
      a , 1 , a , b , c , * , 1
      Heliyon
      Elsevier
      Amyotrophic lateral sclerosis, Treatment gaps, Philippines

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Amyotrophic lateral sclerosis (ALS) is a progressive disease affecting both the upper and lower motor neurons. Much of the management of ALS is supportive with the goal of maximizing patient quality of life. While the Philippines was participative in the “Ice Bucket Challenge” in 2014, it is up for investigation whether substantial changes occurred to improve healthcare for ALS patients. This study aims to evaluate the treatment gaps in the management of ALS in the Philippines through a scoping review. Data on epidemiology, health systems, and pharmacotherapy available regarding ALS in the local setting were synthesized. Nine articles were included. As of July 2023, there were only four indexed studies on ALS from the Philippines. Five of the included articles investigated ALS in Filipino populations but were not authored by Filipinos nor affiliated with Philippine institutions. The available literature showed a distinct lack of local ALS epidemiologic data, as well as limited availability in diagnostic centers, medications, health financing options, and digestible information for Filipinos. The limitations in managing ALS in the country are multifactorial – from political, medical, and social. It is imperative to establish a national database, financing systems, support groups, and accessible diagnostic centers for ALS patients.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: not found
          • Article: not found

          Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature

            Background: Amyotrophic lateral sclerosis (ALS) is relatively rare, yet the economic and social burden is substantial. Having accurate incidence and prevalence estimates would facilitate efficient allocation of healthcare resources. Objective: To provide a comprehensive and critical review of the epidemiological literature on ALS. Methods: MEDLINE and EMBASE (1995-2011) databases of population-based studies on ALS incidence and prevalence reporting quantitative data were analyzed. Data extracted included study location and time, design and data sources, case ascertainment methods and incidence and/or prevalence rates. Medians and interquartile ranges (IQRs) were calculated, and ALS case estimates were derived using 2010 population estimates. Results: In all, 37 articles met the inclusion criteria. In Europe, the median incidence rate (/100,000 population) was 2.08 (IQR 1.47-2.43), corresponding to an estimated 15,355 (10,852-17,938) cases. Median prevalence (/100,000 population) was 5.40 (IQR 4.06-7.89), or 39,863 (29,971-58,244) prevalent cases. Conclusions: Disparity in rates among ALS incidence and prevalence studies may be due to differences in study design or true variations in population demographics such as age and geography, including environmental factors and genetic predisposition. Additional large-scale studies that use standardized case ascertainment methods are needed to more accurately assess the true global burden of ALS.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis

                Bookmark

                Author and article information

                Contributors
                Journal
                Heliyon
                Heliyon
                Heliyon
                Elsevier
                2405-8440
                10 March 2024
                30 March 2024
                10 March 2024
                : 10
                : 6
                : e27944
                Affiliations
                [a ]Department of Neurosciences, College of Medicine and Philippine General Hospital, University of the Philippines Manila, Manila, Philippines
                [b ]Department of Physiology, College of Medicine, University of the Philippines Manila, Manila, Philippines
                [c ]National Teacher Training Center for the Health Professions, University of the Philippines Manila, Manila, Philippines
                Author notes
                [* ]Corresponding author. Department of Physiology, 2nd floor Salcedo Hall, University of the Philippines Manila, Pedro Gil Street, Manila City, National Capital Region, Philippines. crturalde@ 123456up.edu.ph
                [1]

                These authors contributed equally in this work.

                Article
                S2405-8440(24)03975-6 e27944
                10.1016/j.heliyon.2024.e27944
                10950718
                38510000
                9dcab032-3ab9-4d33-a97d-4a7beb03befc
                © 2024 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 11 November 2023
                : 5 March 2024
                : 8 March 2024
                Categories
                Review Article

                amyotrophic lateral sclerosis,treatment gaps,philippines

                Comments

                Comment on this article